Ankush Patel, MD

Postdoctoral Fellow, Academic Writer: Mayo Clinic Department of Laboratory Medicine & Pathology, Division of Computational Pathology & Artificial Intelligence. Rochester, MN.

United States

A love for pathology, informatics, and AI coupled with an inextinguishable drive to illustrate the multi-dimensional landscape of medicine today so that these blueprints may serve to navigate the world of tomorrow.


Peer-Reviewed Publications

Posterior Ischemic Optic Neuropathy Because of Hematologic... : Journal of Neuro-Ophthalmology

Patel, Ankush U. MD; Patel, Uresh S. MD; May, Eugene F. MD Editor(s): Avery, Robert DO; Golnik, Karl C. MD; Froment, Caroline MD, PhD; Wang, An-Guor MD Author Information Department of Laboratory Medicine and Pathology (AUP), Mayo Clinic, Rochester, Minnesota; Department of Radiology (USP), Swedish Medical Center, Seattle, Washington; and Departments of Ophthalmology and Neurology (EFM), University of Washington, Seattle, Washington.

Types and frequency of whole slide imaging scan failures in a clinical high throughput digital...

Digital workflow transformation continues to sweep throughout a diversity of pathology departments spanning the globe following catalyzation of whole slide imaging (WSI) adoption by the SARS-CoV-2 (COVID-19) pandemic. The utility of WSI for a litany of use cases including primary diagnosis has been emphasized during this period, with WSI scanning devices gaining the approval of healthcare regulatory bodies and practitioners alike for clinical applications following extensive validatory efforts.

Anastomosing hemangioma: A case report of a benign tumor often misdiagnosed as a malignant...

Anastomosing hemangioma (AH), a rare benign genitourinary tract hemangioma is subject to frequent misdiagnosis due to its rarity and clinical, histological, and immunohistochemical similarities it shares with several diagnoses, including well-differentiated angiosarcoma (AS). This is particularly true of angiosarcoma, nearly identical to AH when presented in tissue samples of limited size.

Journal of Clinical Images and Medical Case Reports

Case presentation A 37-year-old male presenting to The Ohio State University for evaluation of a three-year duration of intermittent, painless, gross hematuria accompanied by initial episodes of hematospermia prompted a CT urogram investigation indicating a 7.2 cm lobulated ill-defined mass arising from the seminal vesicles.


Catechism (Quiz 18) - PubMed

The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Science Writing

Standardizing Psychedelic Experiences: Research - PsyTech

Psychedelic effects and their impact on mental health symptoms have been well documented in medical literature. However, a more tangible understanding of the different subtypes of the psychedelic experience and their direct relationship to specific therapeutic outcomes remains missing.

The Overlooked Medical Potential of Mescaline - PsyTech

Mescaline may be beneficial in the treatment of alcoholism and mental health disorders, according to researchers from Neural Therapeutics Inc. in a recent publication featured in the medical journal Neuropharmacology. Highlights of the study include: Mescaline appears safe for consumption, with intoxication typically mild and easily treatable.

Patient Selection Psilocybin Therapy Study - PsyTech

Healthcare practitioner beliefs and attitudes concerning psilocybin-assisted therapy (PAT) primarily influence their willingness to offer PAT as a treatment option for eligible patients, according to researchers from the University of Texas Health Science Center's McGovern Medical School.

The Psychedelic
Ketamine and Alcohol: A Dangerous Combo | The Psychedelic

Brazilian researchers reviewed a series of published studies to draw further insight into the effects of combined ketamine and alcohol use. Findings were analyzed in conjunction with known molecular interactions of ketamine and alcohol throughout the body to conclude that when used in combination, the substances held the potential to negatively impact a number of organs including the liver, gallbladder, heart, and kidneys, while also increasing the risk for adverse behavioral and mental...

The Psychedelic
Equality in Psychedelic Terminology | The Psychedelic

Researchers at the Department of Medical Ethics and Health Policy (Perelman School of Medicine, University of Pennsylvania), argued for the development and adoption of a standardized, objective, and medically-founded vocabulary for psychedelics for use by researchers, clinicians, and patient-centric organizations including commercial enterprises. Different language choices were offered to compel thinking from those within the clinical sphere.

The Psychedelic
Ketamine May Enhance Post-Surgery Recovery | The Psychedelic

Ketamine may improve the quality of recovery (QoR) in patients undergoing thoracoscopic, i.e., chest, surgery when given around the time of procedure (perioperatively). Recently published results from a clinical trial conducted at a university hospital suggest that perioperative administration of "S"-ketamine enhanced the quality of recovery in patients who underwent video-assisted thoracic surgery (VATS), including improvements in depression and pain levels experienced after surgery.

The Psychedelic
The Therapeutic Potential of Psilocybin | The Psychedelic

The medical use of psilocybin, the main psychoactive component of psilocybin-producing ("magic") mushrooms, has been explored in a litany of disease states, as recently reported in a comprehensive review evaluating the medical application of psilocybin in a smattering of conditions related to neuropsychiatry.

The Psychedelic
Psilocybin Therapy Demonstrates Efficacy in Treating Patients with Major Depressive Disorder |...

A recent clinical study explored the use of psilocybin therapy as an adjunct to psychotherapy in patients with treatment-resistant depression. Most study participants demonstrated a clinically significant response to psilocybin therapy, with over 50% of patients exhibiting remission from major depressive disorder (MDD). More than 264 million individuals of all ages are affected with MDD worldwide.